xford Biomaterials is a medical devices company founded in 2001 to develop Spidrex: a novel silk-based absorbable biomaterial for use in the repair and regeneration of human tissues.

Our unique technology has wide-ranging market appeal and is being taken up in four separate ventures including cartilage, suturing, and nerve repair products.

For the past two years, efforts have focussed on the development of our Spidrex Bone Graft Material: SilkBone™ - the world’s first absorbable, load bearing, off-the-shelf Bone Graft Material.

Our unique absorbable product combines mechanical support comparable to real bone, with a highly porous and hydrophilic structure such that patient’s own regenerating bone will eventually replace the implant.